Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure.

× No keyword cloud information.

12 in total

Review 1. Pulmonary hypertension with left-sided heart disease.

Authors: Marco Guazzi; Ross Arena
Journal: Nat Rev Cardiol Date: 2010-10-05 Impact factor: 32.419

2. Sildenafil reverses the hypertrophy of mice right ventricle caused by hypoxia but does not reverse the changes in the myosin heavy chain isoforms.

Authors: Mukhallad A Aljanabi; Mahmoud A Alfaqih; Anwar Mohammad A Al-Khayat; Hameed N Bataineh
Journal: Int J Physiol Pathophysiol Pharmacol Date: 2020-06-15

Review 3. Novel therapeutic targets for the treatment of heart failure.

Authors: Juan Tamargo; José López-Sendón
Journal: Nat Rev Drug Discov Date: 2011-06-24 Impact factor: 84.694

4. Mechanisms of the cyclic nucleotide cross-talk signaling network in cardiac L-type calcium channel regulation.

Authors: Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal: J Mol Cell Cardiol Date: 2017-03-29 Impact factor: 5.000

Review 5. Protein kinase G I and heart failure: Shifting focus from vascular unloading to direct myocardial antiremodeling effects.

Authors: Qingwu Kong; Robert M Blanton
Journal: Circ Heart Fail Date: 2013-11 Impact factor: 8.790

6. Treatment for pulmonary hypertension of left heart disease.

Authors: Marco Guazzi; Alessandra Vitelli; Valentina Labate; Ross Arena
Journal: Curr Treat Options Cardiovasc Med Date: 2012-08

7. The hypertensive effect of sorafenib is abolished by sildenafil.

Authors: Hubert Dabiré; Fatou Dramé; Nelly Cita; Bijan Ghaleh
Journal: Cardiooncology Date: 2020-07-13

8. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.

Authors: Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal: J Mol Cell Cardiol Date: 2016-01-07 Impact factor: 5.000

Review 9. Right ventricular pulmonary hypertension.

Authors: Marco Guazzi; Serenella Castelvecchio; Francesco Bandera; Lorenzo Menicanti
Journal: Curr Heart Fail Rep Date: 2012-12

Review 10. Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm.

Authors: Brodie L Loudon; Hannah Noordali; Nicholas D Gollop; Michael P Frenneaux; Melanie Madhani
Journal: Br J Pharmacol Date: 2016-05-06 Impact factor: 8.739